Immunovant (IMVT) Earnings Date, Estimates & Call Transcripts $14.46 -0.10 (-0.69%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$14.47 +0.01 (+0.07%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunovant Earnings Summary Immunovant released Q3 2025 earnings on February 10, 2025, reporting an EPS of -$0.76, which missed analysts' consensus estimates of -$0.68 by $0.08. With a trailing EPS of -$2.62, Immunovant's earnings are expected to decrease next year, from ($2.69) to ($3.08) per share. Upcoming Q4 Earnings DateJun. 4Before Market OpensEstimatedConsensus EPS (Feb. 10) -$0.68 Actual EPS (Feb. 10) -$0.76 Missed By -$0.08 Q3 2025 Earnings ResourcesQ3 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SEC FilingIMVT Upcoming EarningsImmunovant's Q4 2025 earnings is scheduled for Wednesday, June 4, 2025, with a conference call scheduled on Friday, May 30, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Immunovant Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunovant and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIMVT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Immunovant Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.57-$0.41-$0.50Q2 20254-$0.62-$0.54-$0.59Q3 20254-$0.64-$0.54-$0.59Q4 20254-$0.75-$0.56-$0.65 FY 2025 15 -$2.58 -$2.05 -$2.32 Q1 20262-$0.82-$0.62-$0.72Q2 20262-$0.87-$0.64-$0.76Q3 20262-$0.86-$0.64-$0.75Q4 20262-$0.82-$0.67-$0.75 FY 2026 8 -$3.37 -$2.57 -$2.97 Q1 20271-$0.87-$0.87-$0.87Q2 20271-$0.89-$0.89-$0.89Q3 20271-$0.91-$0.91-$0.91 Immunovant Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/4/2025(Estimated)--------2/10/2025Q3 2025-$0.68-$0.76 -$0.08-$0.76--11/7/2024Q2 2025-$0.59-$0.74 -$0.15-$0.74--8/6/2024Q1 2025-$0.53-$0.60 -$0.07-$0.60--5/29/2024Q4 2024-$0.44-$0.52 -$0.08-$0.52--2/12/2024Q3 2024-$0.43-$0.36+$0.07-$0.36--11/9/2023Q2 2024-$0.45-$0.45--$0.45--8/10/2023Q1 2024-$0.44-$0.47 -$0.03-$0.37-- Immunovant Earnings - Frequently Asked Questions When is Immunovant's earnings date? Immunovant has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 4th, 2025 based off last year's report dates. Learn more on IMVT's earnings history. Did Immunovant beat their earnings estimates last quarter? In the previous quarter, Immunovant (NASDAQ:IMVT) missed the analysts' consensus estimate of ($0.68) by $0.08 with a reported earnings per share (EPS) of ($0.76). Learn more on analysts' earnings estimate vs. IMVT's actual earnings. How can I view Immunovant's earnings report? Immunovant's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Immunovant generate each year? Immunovant (NASDAQ:IMVT) has a recorded net income of -$259.34 million. IMVT has generated -$2.62 earnings per share over the last four quarters. What is Immunovant's EPS forecast for next year? Immunovant's earnings are expected to decrease from ($2.69) per share to ($3.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies Ascendis Pharma A/S Earnings Qiagen Earnings Roivant Sciences Earnings Revolution Medicines Earnings Elanco Animal Health Earnings Blueprint Medicines Earnings BridgeBio Pharma Earnings Verona Pharma Earnings TG Therapeutics Earnings Grifols Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout? This page (NASDAQ:IMVT) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
